Cargando…
TSPO as a target for treatments of diseases, including neuropathological disorders
Autores principales: | Veenman, L, Vainshtein, A, Gavish, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632315/ https://www.ncbi.nlm.nih.gov/pubmed/26469960 http://dx.doi.org/10.1038/cddis.2015.294 |
Ejemplares similares
-
Tetrapyrroles as Endogenous TSPO Ligands in Eukaryotes and Prokaryotes: Comparisons with Synthetic Ligands
por: Veenman, Leo, et al.
Publicado: (2016) -
Classical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression: Implications for Mitochondrial Retrograde Signaling
por: Yasin, Nasra, et al.
Publicado: (2017) -
The TSPO Ligands 2-Cl-MGV-1, MGV-1, and PK11195 Differentially Suppress the Inflammatory Response of BV-2 Microglial Cell to LPS
por: Azrad, Maya, et al.
Publicado: (2019) -
Diagnostic and Therapeutic Potential of TSPO Studies Regarding Neurodegenerative Diseases, Psychiatric Disorders, Alcohol Use Disorders, Traumatic Brain Injury, and Stroke: An Update
por: Dimitrova-Shumkovska, Jasmina, et al.
Publicado: (2020) -
Effects of Cigarette Smoke on TSPO-related Mitochondrial Processes
por: Zeineh, Nidal, et al.
Publicado: (2019)